Kailan Sierra-Davidson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria Vaccines | 2 | 2016 | 158 | 0.250 |
Why?
|
Antibodies, Protozoan | 2 | 2016 | 253 | 0.160 |
Why?
|
Parasitemia | 1 | 2016 | 174 | 0.130 |
Why?
|
Ebola Vaccines | 1 | 2015 | 24 | 0.130 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2021 | 806 | 0.130 |
Why?
|
Vaccinia virus | 1 | 2015 | 349 | 0.120 |
Why?
|
Antigens, Protozoan | 1 | 2015 | 322 | 0.110 |
Why?
|
Ebolavirus | 1 | 2015 | 263 | 0.100 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 428 | 0.090 |
Why?
|
Plasmodium falciparum | 2 | 2016 | 1732 | 0.090 |
Why?
|
Malaria, Falciparum | 1 | 2016 | 1077 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2016 | 4479 | 0.070 |
Why?
|
Immunization, Secondary | 2 | 2015 | 340 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5221 | 0.050 |
Why?
|
Liver | 1 | 2016 | 7474 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 4386 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13102 | 0.040 |
Why?
|
Sporozoites | 1 | 2016 | 82 | 0.030 |
Why?
|
Adenoviruses, Simian | 1 | 2015 | 14 | 0.030 |
Why?
|
Vaccines, Subunit | 1 | 2015 | 168 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2879 | 0.030 |
Why?
|
Vaccinia | 1 | 2015 | 76 | 0.030 |
Why?
|
Pan troglodytes | 1 | 2015 | 229 | 0.030 |
Why?
|
HIV-1 | 1 | 2012 | 6939 | 0.030 |
Why?
|
Adenoviruses, Human | 1 | 2015 | 257 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6895 | 0.020 |
Why?
|
Granzymes | 1 | 2012 | 271 | 0.020 |
Why?
|
Germany | 1 | 2012 | 862 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2016 | 2375 | 0.020 |
Why?
|
Protozoan Proteins | 1 | 2015 | 827 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3870 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1607 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2012 | 1369 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1341 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2016 | 10180 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2016 | 3206 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2559 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 16718 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4560 | 0.010 |
Why?
|
Virus Replication | 1 | 2012 | 2534 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2015 | 3176 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2902 | 0.010 |
Why?
|
Vaccination | 1 | 2015 | 3278 | 0.010 |
Why?
|
Viral Load | 1 | 2012 | 3299 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4665 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6538 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5524 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7322 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7913 | 0.010 |
Why?
|
Animals | 3 | 2016 | 168757 | 0.010 |
Why?
|
Young Adult | 2 | 2016 | 56430 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9313 | 0.010 |
Why?
|
Macrophages | 1 | 2012 | 5655 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10481 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 19229 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 13989 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13284 | 0.010 |
Why?
|
Humans | 5 | 2021 | 744343 | 0.010 |
Why?
|
Female | 3 | 2021 | 380194 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16365 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 77449 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 213383 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29063 | 0.010 |
Why?
|
Adult | 2 | 2016 | 214055 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40075 | 0.010 |
Why?
|
Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 85781 | 0.000 |
Why?
|
Male | 2 | 2016 | 350118 | 0.000 |
Why?
|